| 199 |
10.1001/jamaoncol.2018.4475 |
Alpelisib Plus Fulvestrant In Pik3Ca-Altered And
Pik3Ca-Wild-Type Estrogen Receptor<U+2013>Positive Advanced Breast
Cancer |
Juric, Dejan; Janku, Filip; Rodon, Jordi; Burris,
Howard A.; Mayer, Ingrid A.; Schuler, Martin; Seggewiss-Bernhardt, Ruth;
Gil-Martin, Marta; Middleton, Mark R.; Baselga, Jose; Bootle, Douglas;
Demanse, David; Blumenstein, Lars; Schumacher, Karl; Huang, Alan; Quadt,
Cornelia; Rugo, Hope S. |
Jama Oncology |
2019 |
| 218 |
10.1001/jamaoncol.2019.4782 |
|
Sledge, George W.; Toi, Masakazu; Neven, Patrick; Sohn,
Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena;
Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria;
Conte, Pierfranco; Lu, Yi; Barriga, Susana; Hurt, Karla; Frenzel,
Martin; Johnston, Stephen; Llombart-Cussac, Antonio |
Jama Oncology |
2020 |
| 2039 |
10.1002/ijc.32020 |
Molecular Mechanisms Of Resistance To Cdk4/6 Inhibitors
In Breast Cancer: A Review |
|
International Journal Of Cancer |
2019 |
| 2596 |
10.1007/s10549-018-05125-4 |
Palbociclib Plus Letrozole As First-Line Therapy In
Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor
2-Negative Advanced Breast Cancer With Extended Follow-Up |
Rugo, H. S.; Finn, R. S.; Dieras, V.; Ettl, J.;
Lipatov, O.; Joy, A. A.; Harbeck, N.; Castrellon, A.; Iyer, S.; Lu, D.
R.; Mori, A.; Gauthier, E. R.; Bartlett, C. Huang; Gelmon, K. A.;
Slamon, D. J. |
Breast Cancer Research And Treatment |
2019 |
| 3895 |
10.1016/j.ccell.2018.08.008 |
The Genomic Landscape Of Endocrine-Resistant Advanced
Breast Cancers |
Razavi, Pedram; Chang, Matthew T.; Xu, Guotai;
Bandlamudi, Chaitanya; Ross, Dara S.; Vasan, Neil; Cai, Yanyan; Bielski,
Craig M.; Donoghue, Mark T.A.; Jonsson, Philip; Penson, Alexander; Shen,
Ronglai; Pareja, Fresia; Kundra, Ritika; Middha, Sumit; Cheng, Michael
L.; Zehir, Ahmet; Kandoth, Cyriac; Patel, Ruchi; Huberman, Kety; Smyth,
Lillian M.; Jhaveri, Komal; Modi, Shanu; Traina, Tiffany A.; Dang, Chau;
Zhang, Wen; Weigelt, Britta; Li, Bob T.; Ladanyi, Marc; Hyman, David M.;
Schultz, Nikolaus; Robson, Mark E.; Hudis, Clifford; Brogi, Edi; Viale,
Agnes; Norton, Larry; Dickler, Maura N.; Berger, Michael F.;
Iacobuzio-Donahue, Christine A.; Chandarlapaty, Sarat; Scaltriti,
Maurizio; Reis-Filho, Jorge S.; Solit, David B.; Taylor, Barry S.;
Baselga, Jose |
Cancer Cell |
2018 |
| 3898 |
10.1016/j.ccell.2018.11.006 |
Loss Of The Fat1 Tumor Suppressor Promotes Resistance
To Cdk4/6 Inhibitors Via The Hippo Pathway |
Li, Zhiqiang; Razavi, Pedram; Li, Qing; Toy, Weiyi;
Liu, Bo; Ping, Christina; Hsieh, Wilson; Sanchez-Vega, Francisco; Brown,
David N.; Da Cruz Paula, Arnaud F.; Morris, Luc; Selenica, Pier;
Eichenberger, Emily; Shen, Ronglai; Schultz, Nikolaus; Rosen, Neal;
Scaltriti, Maurizio; Brogi, Edi; Baselga, Jose; Reis-Filho, Jorge S.;
Chandarlapaty, Sarat, 0000-0003-4532-8053 |
Cancer Cell |
2018 |
| 4683 |
10.1016/j.chembiol.2019.05.005 |
Multiomics Profiling Establishes The Polypharmacology
Of Fda-Approved Cdk4/6 Inhibitors And The Potential For Differential
Clinical Activity |
Hafner, Marc, 0000-0003-1337-7598; Mills, Caitlin E.;
Subramanian, Kartik; Chen, Chen; Chung, Mirra; Boswell, Sarah A.;
Everley, Robert A.; Liu, Changchang; Walmsley, Charlotte S.; Juric,
Dejan; Sorger, Peter K. |
Cell Chemical Biology |
2019 |
| 10254 |
10.1016/s1470-2045(18)30292-4 |
Ribociclib Plus Endocrine Therapy For Premenopausal
Women With Hormone-Receptor-Positive, Advanced Breast Cancer
(Monaleesa-7): A Randomised Phase 3 Trial |
Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke,
Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A; Chow, Louis;
Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Villanueva Vazquez,
Rafael; Jung, Kyung Hae; Babu, K Govind; Wheatley-Price, Paul; De
Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir,
Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan;
Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen |
The Lancet Oncology |
2018 |
| 10301 |
10.1016/s1470-2045(19)30420-6 |
Endocrine Treatment Versus Chemotherapy In
Postmenopausal Women With Hormone Receptor-Positive, Her2-Negative,
Metastatic Breast Cancer: A Systematic Review And Network
Meta-Analysis |
Giuliano, Mario; Schettini, Francesco; Rognoni, Carla;
Milani, Manuela; Jerusalem, Guy; Bachelot, Thomas; De Laurentiis,
Michelino; Thomas, Guglielmo; De Placido, Pietro; Arpino, Grazia; De
Placido, Sabino; Cristofanilli, Massimo; Giordano, Antonio; Puglisi,
Fabio; Pistilli, Barbara; Prat, Aleix; Del Mastro, Lucia; Venturini,
Sergio; Generali, Daniele |
The Lancet Oncology |
2019 |
| 10318 |
10.1016/s1470-2045(19)30804-6 |
Cdk4/6 Inhibitor Treatment For Patients With Hormone
Receptor-Positive, Her2-Negative, Advanced Or Metastatic Breast Cancer:
A Us Food And Drug Administration Pooled Analysis |
Gao, Jennifer J; Cheng, Joyce; Bloomquist, Erik;
Sanchez, Jacquelyn; Wedam, Suparna B; Singh, Harpreet; Amiri-Kordestani,
Laleh; Ibrahim, Amna; Sridhara, Rajeshwari; Goldberg, Kirsten B;
Theoret, Marc R; Kluetz, Paul G; Blumenthal, Gideon M; Pazdur, Richard;
Beaver, Julia A; Prowell, Tatiana M |
The Lancet Oncology |
2020 |
| 10319 |
10.1016/s1470-2045(19)30817-4 |
Fulvestrant Plus Capivasertib Versus Placebo After
Relapse Or Progression On An Aromatase Inhibitor In Metastatic,
Oestrogen Receptor-Positive Breast Cancer (Faktion): A Multicentre,
Randomised, Controlled, Phase 2 Trial |
Jones, Robert H; Casbard, Angela; Carucci, Margherita;
Cox, Catrin; Butler, Rachel; Alchami, Fouad; Madden, Tracie-Ann; Bale,
Catherine; Bezecny, Pavel; Joffe, Johnathan; Moon, Sarah; Twelves,
Chris; Venkitaraman, Ramachandran; Waters, Simon; Foxley, Andrew;
Howell, Sacha J |
The Lancet Oncology |
2020 |
| 12988 |
10.1038/s41467-019-09068-2 |
Aberrant Fgfr Signaling Mediates Resistance To Cdk4/6
Inhibitors In Er+ Breast Cancer |
|
Nature Communications |
2019 |
| 13412 |
10.1038/s41523-018-0097-z |
Monarch 3 Final Pfs: A Randomized Study Of Abemaciclib
As Initial Therapy For Advanced Breast Cancer |
Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im,
Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck,
Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji;
Goetz, Matthew P. |
Npj Breast Cancer |
2019 |
| 14568 |
10.1038/s41588-018-0287-5 |
Acquired Her2 Mutations In Er+ Metastatic Breast Cancer
Confer Resistance To Estrogen Receptor<U+2013>Directed
Therapies |
Nayar, Utthara; Cohen, Ofir; Kapstad, Christian; Cuoco,
Michael S.; Waks, Adrienne G., 0000-0001-5649-7229; Wander, Seth A.;
Painter, Corrie; Freeman, Samuel; Persky, Nicole S.; Marini, Lori;
Helvie, Karla; Oliver, Nelly; Rozenblatt-Rosen, Orit; Ma, Cynthia X.;
Regev, Aviv; Winer, Eric P.; Lin, Nancy U.; Wagle, Nikhil,
0000-0003-3332-9438 |
Nature Genetics |
2018 |
| 16074 |
10.1056/nejmoa1810527 |
Overall Survival With Palbociclib And Fulvestrant In
Advanced Breast Cancer |
Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil;
Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco;
Demichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck,
Nadia; Loibl, Sibylle; Andre, Fabrice; Puyana Theall, Kathy; Huang, Xin;
Giorgetti, Carla; Huang Bartlett, Cynthia; Cristofanilli, Massimo |
New England Journal Of Medicine |
2018 |
| 16087 |
10.1056/nejmoa1813904 |
Alpelisib For Pik3Ca-Mutated, Hormone
Receptor<U+2013>Positive Advanced Breast Cancer |
Andre, Fabrice; Ciruelos, Eva; Rubovszky, Gabor;
Campone, Mario; Loibl, Sibylle; Rugo, Hope S.; Iwata, Hiroji; Conte,
Pierfranco; Mayer, Ingrid A.; Kaufman, Bella; Yamashita, Toshinari; Lu,
Yen-Shen; Inoue, Kenichi; Takahashi, Masato; Papai, Zsuzsanna; Longin,
Anne-Sophie; Mills, David; Wilke, Celine; Hirawat, Samit; Juric,
Dejan |
New England Journal Of Medicine |
2019 |
| 16114 |
10.1056/nejmoa1903765 |
Overall Survival With Ribociclib Plus Endocrine Therapy
In Breast Cancer |
Im, Seock-Ah; Lu, Yen-Shen; Bardia, Aditya; Harbeck,
Nadia; Colleoni, Marco; Franke, Fabio; Chow, Louis; Sohn, Joohyuk; Lee,
Keun-Seok; Campos-Gomez, Saul; Villanueva-Vazquez, Rafael; Jung,
Kyung-Hae; Chakravartty, Arunava; Hughes, Gareth; Gounaris, Ioannis;
Rodriguez-Lorenc, Karen; Taran, Tetiana; Hurvitz, Sara; Tripathy,
Debu |
New England Journal Of Medicine |
2019 |
| 16139 |
10.1056/nejmoa1911149 |
Overall Survival With Ribociclib Plus Fulvestrant In
Advanced Breast Cancer |
Slamon, Dennis J.; Neven, Patrick; Chia, Stephen;
Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova,
Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel;
Nusch, Arnd; Sonke, Gabe S.; De La Cruz-Merino, Luis; Beck, J. Thaddeus;
Pivot, Xavier; Sondhi, Manu; Wang, Yingbo; Chakravartty, Arunava;
Rodriguez-Lorenc, Karen; Taran, Tetiana; Jerusalem, Guy |
New England Journal Of Medicine |
2020 |
| 16956 |
10.1093/annonc/mdy155 |
Updated Results From Monaleesa-2, A Phase Iii Trial Of
First-Line Ribociclib Plus Letrozole Versus Placebo Plus Letrozole In
Hormone Receptor-Positive, Her2-Negative Advanced Breast Cancer |
|
Annals Of Oncology |
2018 |
| 18905 |
10.1126/science.aaw9032 |
|
Vasan, Neil, 0000-0003-1779-484X; Razavi, Pedram,
0000-0003-4236-0576; Johnson, Jared L., 0000-0003-1802-6527; Shao, Hong;
Shah, Hardik, 0000-0001-7967-3811; Antoine, Alesia, 0000-0003-4587-322X;
Ladewig, Erik, 0000-0002-6661-1803; Gorelick, Alexander,
0000-0001-6736-8246; Lin, Ting-Yu, 0000-0002-8335-364X; Toska, Eneda,
0000-0002-8974-9792; Xu, Guotai, 0000-0001-5265-3407; Kazmi, Abiha;
Chang, Matthew T.; Taylor, Barry S., 0000-0002-3355-9471; Dickler, Maura
N.; Jhaveri, Komal; Chandarlapaty, Sarat, 0000-0003-4532-8053; Rabadan,
Raul, 0000-0001-7946-9255; Reznik, Ed, 0000-0002-6511-5947; Smith,
Melissa L., 0000-0001-7151-3207; Sebra, Robert; Schimmoller, Frauke;
Wilson, Timothy R.; Friedman, Lori S., 0000-0001-9127-9892; Cantley,
Lewis C., 0000-0002-1298-7653; Scaltriti, Maurizio, 0000-0002-5522-1447;
Baselga, Jose, 0000-0003-1361-4063 |
Science |
2019 |
| 19512 |
10.1158/1078-0432.ccr-19-0751 |
Biomarker Analyses Of Response To Cyclin-Dependent
Kinase 4/6 Inhibition And Endocrine Therapy In Women With
Treatment-Naive Metastatic Breast Cancer |
Finn, Richard S.; Liu, Yuan; Zhu, Zhou; Martin, Miguel,
0000-0001-9237-3231; Rugo, Hope S.; Dieras, Veronique; Im, Seock-Ah,
0000-0002-5396-6533; Gelmon, Karen A.; Harbeck, Nadia,
0000-0002-9744-7372; Lu, Dongrui R.; Gauthier, Eric; Huang Bartlett,
Cynthia; Slamon, Dennis J. |
Clinical Cancer Research |
2019 |
| 19526 |
10.1158/2159-8290.cd-18-0264 |
The Genetic Landscape And Clonal Evolution Of Breast
Cancer Resistance To Palbociclib Plus Fulvestrant In The Paloma-3
Trial |
O’Leary, Ben; Cutts, Rosalind J.; Liu, Yuan; Hrebien,
Sarah; Huang, Xin; Fenwick, Kerry; Andre, Fabrice; Loibl, Sibylle; Loi,
Sherene, 0000-0001-6137-9171; Garcia-Murillas, Isaac,
0000-0001-8183-7969; Cristofanilli, Massimo; Huang Bartlett, Cynthia;
Turner, Nicholas C. |
Cancer Discovery |
2018 |
| 19533 |
10.1158/2159-8290.cd-18-0830 |
|
Costa, Carlotta; Wang, Ye; Ly, Amy; Hosono, Yasuyuki;
Murchie, Ellen; Walmsley, Charlotte S.; Huynh, Tiffany; Healy,
Christopher, 0000-0001-5916-5115; Peterson, Rachel; Yanase, Shogo;
Jakubik, Charles T.; Henderson, Laura E.; Damon, Leah J.,
0000-0002-0863-0328; Timonina, Daria; Sanidas, Ioannis; Pinto,
Christopher J.; Mino-Kenudson, Mari, 0000-0002-9092-2265; Stone, James
R.; Dyson, Nicholas J.; Ellisen, Leif W.; Bardia, Aditya; Ebi,
Hiromichi, 0000-0003-3155-7576; Benes, Cyril H., 0000-0002-8751-9707;
Engelman, Jeffrey A.; Juric, Dejan |
Cancer Discovery |
2019 |
| 20220 |
10.1200/jco.18.00925 |
Cyclin E1 Expression And Palbociclib Efficacy In
Previously Treated Hormone Receptor<U+2013>Positive Metastatic
Breast Cancer |
Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi,
Sherene; Colleoni, Marco; Loibl, Sibylle; Demichele, Angela; Harbeck,
Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang,
Zhe; Giorgetti, Carla; Arnedos, Monica; Huang Bartlett, Cynthia;
Cristofanilli, Massimo |
Journal Of Clinical Oncology |
2019 |
| 20248 |
10.1200/jco.19.00368 |
Capivasertib Plus Paclitaxel Versus Placebo Plus
Paclitaxel As First-Line Therapy For Metastatic Triple-Negative Breast
Cancer: The Pakt Trial |
Schmid, Peter; Abraham, Jacinta; Chan, Stephen;
Wheatley, Duncan; Brunt, Adrian Murray; Nemsadze, Gia; Baird, Richard
D.; Park, Yeon Hee; Hall, Peter S.; Perren, Timothy; Stein, Robert C.;
Mangel, Laszlo; Ferrero, Jean-Marc; Phillips, Melissa; Conibear, John;
Cortes, Javier; Foxley, Andrew; De Bruin, Elza C.; Mcewen, Robert;
Stetson, Daniel; Dougherty, Brian; Sarker, Shah-Jalal; Prendergast,
Aaron; Mclaughlin-Callan, Max; Burgess, Matthew; Lawrence, Cheryl;
Cartwright, Hayley; Mousa, Kelly; Turner, Nicholas C. |
Journal Of Clinical Oncology |
2020 |
| 20321 |
10.1200/jco.2018.78.9909 |
Phase Iii Randomized Study Of Ribociclib And
Fulvestrant In Hormone Receptor<U+2013>Positive, Human Epidermal
Growth Factor Receptor 2<U+2013>Negative Advanced Breast Cancer:
Monaleesa-3 |
Slamon, Dennis J.; Neven, Patrick; Chia, Stephen;
Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova,
Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel;
Nusch, Arnd; Sonke, Gabe S.; De La Cruz-Merino, Luis; Beck, J. Thaddeus;
Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Rodriguez Lorenc, Karen;
Miller, Michelle; Taran, Tetiana; Jerusalem, Guy |
Journal Of Clinical Oncology |
2018 |
| 20634 |
10.1530/erc-18-0317 |
Overcoming Cdk4/6 Inhibitor Resistance In Er-Positive
Breast Cancer |
Portman, Neil; Alexandrou, Sarah; Carson, Emma; Wang,
Shudong; Lim, Elgene; Caldon, C Elizabeth |
Endocrine-Related Cancer |
2019 |
| 21011 |
10.3389/fonc.2019.00666 |
Mechanisms Of Resistance To Cdk4/6 Inhibitors:
Potential Implications And Biomarkers For Clinical Practice |
Mccartney, Amelia; Migliaccio, Ilenia; Bonechi,
Martina; Biagioni, Chiara; Romagnoli, Dario; De Luca, Francesca;
Galardi, Francesca; Risi, Emanuela; De Santo, Irene; Benelli, Matteo;
Malorni, Luca; Di Leo, Angelo |
Frontiers In Oncology |
2019 |